Arowana

Talu Ventures is an early stage technology investor in Australia, with a particular focus on biotechnology, medical devices and pharmaceuticals. Talu was founded in 2012 by three of the partners of CM Capital. Talu's founders have dedicated their careers to the IT and biotech industries and they understand the challenges of building companies from the ground up. In collaboration with Talu's Industry Advisors, portfolio companies can draw upon more than a century of leadership roles within a broad spectrum of successful companies. Talu has been the lead investor in more than 90 percent of its investments.

PieLAB Venture Partners, now operating as PieLAB Capital, partners with established, profitable Australian small and medium-sized businesses through long-term ownership, across sectors, and prefers never to sell the businesses it invests in. It began in 2016 with a fund that invested in businesses providing services to the real estate sector, and now invests through the evergreen PieLAB Council Capital Fund.

Backing great Australian start-ups is in our DNA. We are a team of investors, entrepreneurs and business leaders with a passion for building businesses and we have been successful in doing so. To date, Aura Group has been an integral part of the success stories of a number of local start-ups from a variety of sectors. These include Catapult Sports (global leader in wearable analytics), Finsure (Australia's fastest growing mortgage aggregator) and InStitchu (Australia's leading online provider of tailored menswear). The Aura Investment Doctrine has been shaped through the years of experience we have in this asset class both as founders and investors. It is a widely referenced document within our firm and has become our philosophy for the Venture Capital landscape. This Doctrine outlines key criteria that must be observed when identifying new opportunities and includes engaging with a proven concept, Identification of positive thematics, Deep assessment of the business environment, Ensuring a clear path to profitability and Partnering with a strong management team. If a company does not possess all of these characteristics we simply will not invest.

Focusing on providing Series A funding to high-growth technology startups, Full Circle is an entrepreneur-led venture capital firm that builds value-added partnerships between investors and founders. Full Circle connects both sides of the VC equation, helping realise value held at both the limited partner and portfolio level. We look for software companies with revenue and strong growth that need venture capital to expand their business.

Artesian Capital Management is a global alternative asset manager running separate debt and venture platforms and managing capital on behalf of institutional and other investors.

DSG Consumer Partners invests in consumer businesses in India and Southeast Asia, working with founders to develop and grow their brands.

Southern Cross Venture Partners backs promising entrepreneurs to build successful companies with global potential. The funds are currently focused on technology, energy and resources (including renewable technology) at the seed, early and growth stages. We are uniquely placed to help entrepreneurs looking to expand globally, with presence in the United States, Australia and Asia, through partnerships with SBCVC (Softbank China). We assist our entrepreneurs by catalysing the right connections, bringing the lessons of experience, acting as a trusted partner and sharing in the vision of our entrepreneurs to build great companies.

A venture capital firm investing in early and growth-stage Australian B2B technology companies that are scaling to the UK or USA.

Uniseed manages Commercialisation and Venture Funds that invest in companies commercialising research from university and research partners, including early-stage deep-tech and life-sciences businesses.

Getting Australian Companies into the Fight. Backing founders developing technologies that enhance the lethality and survivability of our Warfighters.

OneVentures is an Australian investment manager with technology growth-equity and clinical-stage life-sciences investment pillars, alongside a growth-credit practice providing debt facilities to technology companies.